In This Section

SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant

Grant Amount $8,000,000 USD
Grant Term3 Years
Start of Grant Term07/01/2014
Letter of Intent Deadline11/07/2013 12:00 AM
Application Deadline11/07/2013 12:00 AM
Decision Date3/31/2014 11:55:00 PM
Description

The AACR, on behalf of Stand Up To Cancer (SU2C) and the Lustgarten Foundation, and the Fox Family Foundation, calls upon members of the cancer community to contribute their ideas to the groundbreaking SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant.

We invite submission of ideas for a translational cancer research project that addresses critical problems in pancreatic cancer patient care through convergence research. Convergence represents a broad rethinking of scientific research in order to capitalize on a range of knowledge bases including microbiology, computer science, engineering design, nanotechnology, and other fields. The project should include therapeutic interventions for pancreatic cancer, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. The project must be designed to accelerate the application of therapeutic agents to the clinic (i.e., lead to patient involvement within 2-3 years from the beginning of the grant) and include research brings together biology (e.g. genomics, epigenetics, proteomics, and/or other biological fields) and at least one additional field of research such as physics, engineering, or immunology. Proposals for Dream Team research projects must present plans indicating how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.

Letters of Intent will be reviewed by the SU2C-Lustgarten Joint Scientific Advisory Committee (JSAC), and Teams with the most promising idea submissions will be invited to submit full proposals. The JSAC will select a SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team from the invited proposals. The SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team will be awarded up to $8 million over the three-year term of the grant.

Eligibility Criteria

We invite submission of ideas for a translational cancer research project that addresses critical problems in pancreatic cancer patient care through convergence research. Convergence represents a broad rethinking of scientific research in order to capitalize on a range of knowledge bases including microbiology, computer science, engineering design, nanotechnology, and other fields. The project should include therapeutic interventions for pancreatic cancer, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. The project must be designed to accelerate the application of therapeutic agents to the clinic (i.e., lead to patient involvement within 2-3 years from the beginning of the grant) and include research brings together biology (e.g. genomics, epigenetics, proteomics, and/or other biological fields) and at least one additional field of research such as physics, engineering, or immunology. Proposals for Dream Team research projects must present plans indicating how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.

Application Instructions

Complete Program Guidelines and Submission Instructions are available below and on the proposalCENTRAL website.